These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6569064)

  • 21. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1983; 96():1-9. PubMed ID: 6388097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study.
    Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE
    Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.
    Tobert JA; Bell GD; Birtwell J; James I; Kukovetz WR; Pryor JS; Buntinx A; Holmes IB; Chao YS; Bolognese JA
    J Clin Invest; 1982 Apr; 69(4):913-9. PubMed ID: 6918402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.
    Illingworth DR; Connor WE
    Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of pravastatin in relation to low density lipoprotein receptor activity.
    Hayashi H; Naito C; Ito H; Kawamura M; Miyazaki S
    Curr Med Res Opin; 1990; 12(2):100-7. PubMed ID: 2118022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.
    Grundy SM; Vega GL; Bilheimer DW
    Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.
    Farnsworth WH; Hoeg JM; Maher M; Brittain EH; Sherins RJ; Brewer HB
    J Clin Endocrinol Metab; 1987 Sep; 65(3):546-50. PubMed ID: 3114306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP; Illingworth DR
    Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    N Engl J Med; 1981 Aug; 305(9):478-82. PubMed ID: 7254297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia.
    Clauss SB; Holmes KW; Hopkins P; Stein E; Cho M; Tate A; Johnson-Levonas AO; Kwiterovich PO
    Pediatrics; 2005 Sep; 116(3):682-8. PubMed ID: 16140708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Leuven JA; Schouten JA; Stalenhoef AF
    Lancet; 1986 Oct; 2(8513):936-9. PubMed ID: 2877129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    Atherosclerosis; 2002 Nov; 165(1):137-44. PubMed ID: 12208479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.
    Vega GL; Grundy SM
    JAMA; 1987 Jan; 257(1):33-8. PubMed ID: 3537351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria.
    Golper TA; Illingworth DR; Morris CD; Bennett WM
    Am J Kidney Dis; 1989 Apr; 13(4):312-20. PubMed ID: 2650539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
    Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes.
    Cuthbert JA; Lipsky PE
    Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
    Kawashiri MA; Nohara A; Noguchi T; Tada H; Nakanishi C; Mori M; Konno T; Hayashi K; Fujino N; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Am J Cardiol; 2012 Feb; 109(3):364-9. PubMed ID: 22112743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.